TrialAnnals of surgical oncology2016

Results of a Randomized Controlled Multicenter Phase III Trial of Percutaneous Hepatic Perfusion Compared with Best Available Care for Patients with Melanoma Liver Metastases.

Marybeth S Hughes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.